Corvus Pharmaceuticals Inc. (CRVS)
Market Closed
16 Oct, 08:00 PM
$
9. 52
-0.33
-3.3503%
$
884.63M Market Cap
- P/E Ratio
- Div Yield
1.04M Volume
-0.55 Eps
$ 9.85
Previous Close 
Want to track CRVS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Corvus Pharmaceuticals Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| NCG Noah C Goldberg Jain Global LLC | 12,525 | $187,124 | $123,371.25 | -$63,752.75 | -34.07% |
 Zachary Canonico DIADEMA PARTNERS LP | 294,811 | $4.33M | $2.93M | -$1.4M | -32.3% |
 AMY TEH Arrowpoint Investment Partners (Singapore) Pte. Ltd. | 15,112 | $225,773 | $145,938.1 | -$79,834.9 | -35.36% |
 Mark Schafer Police & Firemen's Retirement System of New Jersey | 18,016 | $109,516.79 | $168,990.08 | $59,473.29 | 54.31% |
 Yuen Man Lee Persistent Asset Partners Ltd. | 74,796 | $1.1M | $709,814.04 | -$388,402.22 | -35.37% |
| WJ William Jones TEMA ETFs LLC | 136,276 | $1.43M | $1.29M | -$136,073.97 | -9.51% |
| GFM GF Fund Management Co. Ltd. GF Fund Management Co. Ltd. | 1,750 | $11,510.13 | $16,625.17 | $5,115.04 | 44.44% |
2026 © Marketlog. All Rights Reserved.
